Search
for
Sort by
Research 601–630 of 1000+
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Drug Reactions Affecting Hair: Diagnosis
- Tofacitinib for the treatment of lichen planopilaris: A case series
- CHRONIC TELOGEN EFFLUVIUM
- Management of Hair Loss
- Analysis of Serum Zinc and Copper Concentrations in Hair Loss
- Alopecia areata: An update
- Platelet Preparations for Use in Facial Rejuvenation and Wound Healing: A Critical Review of Current Literature
- Clinical evaluation of alopecias using a handheld dermatoscope
- Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil®, Finasteride®, and Adult Stem Cell-Based Therapy
- Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis
- DRUG‐ASSOCIATED ALOPECIA
- Serum Ferritin and Vitamin D in Female Hair Loss: Do They Play a Role?
- Anagen effluvium
- Adipose-derived cellular and cell-derived regenerative therapies in dermatology and aesthetic rejuvenation
- Traction alopecia: the root of the problem
- Female Pattern Hair Loss
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Alopecia areata update
- Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus
- Evaluating the Efficacy of Different Platelet-Rich Plasma Regimens for Management of Androgenetic Alopecia: A Single-Center, Blinded, Randomized Clinical Trial
- Hair Breakage as a Presenting Sign of Early or Occult Central Centrifugal Cicatricial Alopecia
- Cicatricial (Scarring) Alopecias
- Systemic treatments for alopecia areata: A systematic review
- Loose anagen hair syndrome
- Drug-Induced Hair Disorders
- Short anagen syndrome
- Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area